Antidepressant use and treatment of overactive bladder disorder

Drug Benefit Trends

Volumn 13, Issue 12, 2001, Pages

  Zhou, Zhiyuan ^a   Jensen, Gail A ^a   Barr, Charles E ^a   Torigoe, Yasuhiro ^a  

^a PFIZER INC   (United States)

Author keywords

Antidepressant; Overactive bladder disorder

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DICYCLOVERINE; FLAVOXATE; FLUOXETINE; HYOSCYAMINE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; OXYBUTYNIN; PAROXETINE; PHENELZINE; PROPANTHELINE BROMIDE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOLTERODINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BLADDER DYSFUNCTION; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DRUG USE; FEMALE; HEALTH INSURANCE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; OVERACTIVE BLADDER DISORDER; PRESCRIPTION; PREVALENCE; PSYCHOSOCIAL DISORDER; RETROSPECTIVE STUDY; RISK; SYMPTOM; TIME;

EID: 17144468494     PISSN: 10805826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. The overactive bladder: An overview for primary care health providers
2. Tolterodine, a new antimuscarinic agent: As effective but better tolerated than oxybutynin in patients with an overactive bladder
3. The patient with overactive bladder symptoms and quality-of-life issues
4. Urge incontinence: The patient's perspective
5. Overactive bladder significantly affects quality of life
6. A review of the quality-of-life aspects of urinary urge incontinence
7. Quality of life of incontinent men after radical prostatectomy
8. Urinary incontinence in the community: Analysis of a MORI poll
9. The influence of urinary incontinence on the quality of life of women
10. Quality of line and urinary incontinence
11. Urinary incontinence and depression
12. Insurance claim costs for overactive bladder disorder
13. Prevalence of depression and its correlates in older adults
14. Depression and disability in the elderly: Reciprocal relations and changes with age
15. Physical disability and depression: A longitudinal analysis
16. Social support and depressive symptoms in the elderly
17. The relationship between chronic illness and depression in a community of urban black elderly persons
18. The costs of depression: Direct and indirect, treatment versus nontreatment
19. The economic burden of anxiety disorders in the 1990s
20. Use of antidepressants among elderly subjects: Trends and contributing factors
21. Drug therapy for urinary incontinence
22. What does treatment of depression really cost?
23. Antidepressant utilization patterns in a national managed care organization
24. Age and depression
25. Women's increased vulnerability to mood disorders: Integrating psychobiology and epidemiology
26. Depression and medical illness in later life: Report of a symposium